The effect of laparoscopic treatment of polycystic ovarian disease by CO2-laser or Nd:YAG laser.

The feasibility and efficacy of laparoscopic CO2 laser and Nd:YAG non-contact laser application for the treatment of polycystic ovarian disease (PCOD) were evaluated in 30 patients (19 patients treated with the CO2 laser, and 11 with the Nd:YAG laser). The criteria for inclusion of PCOD in our study were: amenorrhea or oligomenorrhea with chronic anovulation, failure to ovulate in response to clomide or human menopausal gonadotropin, elevated serum levels of luteinizing hormone (LH) or an elevated LH/follicle-stimulating hormone ratio, exaggerated LH response to gonadotrophin-releasing hormone (GnRH), elevated serum androgen levels, and ultrasonographic features of polycystic ovaries. Eight pregnancies after CO2 laser and three after Nd:YAG laser were achieved. Decline of serum androgen concentrations was noted in both groups, but was significantly higher in the Nd:YAG laser group (from 3.4 +/- 0.4 ng/ml to 2.2 +/- 0.2 ng/ml). Nine patients checked before and after laser treatment showed a decrease in the characteristically exaggerated pituitary response to exogenous GnRH injection. There were no consistent findings of the pattern in LH pulsatility studied in 5 patients after Nd:YAG laser treatment. Ovarian status was investigated in 11 patients by second-look laparoscopy or cesarian section. There were absolutely no adhesions after Nd:YAG laser coagulation. Filmy adhesions were seen in 3 patients in the CO2 laser group.
AuthorsG Keckstein, W Rossmanith, K Spatzier, V Schneider, K Börchers, R Steiner
JournalSurgical endoscopy (Surg Endosc) Vol. 4 Issue 2 Pg. 103-7 ( 1990) ISSN: 0930-2794 [Print] GERMANY, WEST
PMID2142827 (Publication Type: Journal Article)
Chemical References
  • Testosterone
  • Androstenedione
  • Luteinizing Hormone
  • Amenorrhea (etiology)
  • Androstenedione (metabolism)
  • Female
  • Humans
  • Infertility, Female (etiology, surgery)
  • Laparoscopy (adverse effects, methods)
  • Laser Therapy (adverse effects, methods)
  • Luteinizing Hormone (secretion)
  • Menstrual Cycle
  • Oligomenorrhea (etiology)
  • Ovarian Diseases (etiology)
  • Ovulation (physiology)
  • Polycystic Ovary Syndrome (complications, surgery)
  • Testosterone (metabolism)
  • Tissue Adhesions (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: